Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zopiclone for ASV Compliance in CSA
NCT02820441Phase 4Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- May 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zopiclone in central sleep apnea (CSA), sponsored by CHU Grenoble Alpes. Started May 2016; status: terminated.
02
Drugs
zopiclone
03
Conditions
central sleep apnea (CSA)
Beyond the preview
Go deeper on NCT02820441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02820441.